NCT06013982Completed
Stroke and Anxiety Reduction
Impact of a Structured Anxiety Reduction Program on Anxiety in Patients Who Are Discharged to Home Following an Acute Stroke in an Academic Medical Center
Source: ClinicalTrials.gov · Last updated 18 Apr 2025
Brief summary (registry, in English)
The purpose of this pilot study is to explore the impact that a structured anxiety reduction intervention program has on patients being discharged to home following an acute stroke in an academic medical center. Eligible participants will be screened and recruited by the research team through daily rounds. After completing the informed consent process, the research team will pull demographic information from the electronic health record (EHR) and REDCAP that includes ethnicity and support system. Participants will complete the Anxiety Screen Questionnaire (GAD-7 ANXIETY SURVEY) and will be provided with information regarding stroke support groups available with additional NYU Langone Health and the American Heart Association internet-based information regarding anxiety reduction (NYU Langone Health Anxiety Reduction Bundle). The participants will be encouraged to attend a stroke support group for 3 months and utilize the NYU Langone Health Anxiety Reduction Bundle provided. At the completion of the intervention (3 months), participants will be provided with the GAD-7 ANXIETY SURVEY again and a survey that includes open-ended questions and a program evaluation by email. Analysis will occur after final data is collected.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 34 (actual)
- First submitted
- 23 Aug 2023
- Start date
- 22 Aug 2023
- Primary completion date
- 23 Jan 2025
- Lead sponsor
- NYU Langone Health
- Diseases
- Stroke
- NCT number
- NCT06013982
What you commit to
- Study type: Interventional
- Participants enrolled: 34
- From 22 Aug 2023 to the primary completion date, 23 Jan 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Not diagnosed with an acute stroke
- Length of hospital stay greater than 6 days from the initial presentation of stroke symptoms
Other
- Unable to speak, read and write in English as this intervention is not available in other languages and at this time, funding is not available in order to have the resources provided translated or to have translation services available for these participants.
- Not discharged to home
- No internet access including email
- Unwilling or unable to participate in an anxiety reduction program
- Cognitively impaired
- Not medically stable
Who the study is looking for
- Be diagnosed with an acute stroke
- Able to speak, read and write in English
- Not cognitively impaired, as per standard of care documentation in the EHR regarding mental status.
- Discharged to home
- Internet access including email
- Willingness to participate in an anxiety reduction program
- Length of hospital stay less than 5 days from the initial presentation of stroke symptoms
- Must be medically stable
Age in the registry: 18 years to 89 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| NYU Langone Health Coordinator of this site? Confirm its status | New York | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.